glp 1 agonist cardioprotective Understanding GLP-1 receptor agonists and their impact on drug discovery Major physiological roles of GLP-1

RELIEVES THE 4 WORST GLP-1 SIDE EFFECTS IN ONE FORMULA Constipation that lasts 46 days

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

There are no large trials proving safety, but early data suggests milk transfer is low

This article reviews lactation safety data, medication transfer mechanisms, and what mothers should know before starting tr

India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide

Agents that agonize glucagon-like peptide 1 receptors, including those that co-agonize other anorexigenic hormone receptors, lead to substantial weight loss and benefits in people with varying obesity-related complications, with further trials underway